Literature DB >> 29746834

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.

Alberto Peretti1, Eileen M Geoghegan1, Diana V Pastrana1, Sigrun Smola2, Pascal Feld2, Marlies Sauter2, Stefan Lohse2, Mayur Ramesh3, Efrem S Lim4, David Wang4, Cinzia Borgogna5, Peter C FitzGerald1, Valery Bliskovsky1, Gabriel J Starrett6, Emily K Law7, Reuben S Harris7, J Keith Killian1, Jack Zhu1, Marbin Pineda1, Paul S Meltzer1, Renzo Boldorini8, Marisa Gariglio5, Christopher B Buck9.   

Abstract

BK polyomavirus (BKV) frequently causes nephropathy (BKVN) in kidney transplant recipients (KTRs). BKV has also been implicated in the etiology of bladder and kidney cancers. We characterized BKV variants from two KTRs who developed BKVN followed by renal carcinoma. Both patients showed a swarm of BKV sequence variants encoding non-silent mutations in surface loops of the viral major capsid protein. The temporal appearance and disappearance of these mutations highlights the intra-patient evolution of BKV. Some of the observed mutations conferred resistance to antibody-mediated neutralization. The mutations also modified the spectrum of receptor glycans engaged by BKV during host cell entry. Intriguingly, all observed mutations were consistent with DNA damage caused by antiviral APOBEC3 cytosine deaminases. Moreover, APOBEC3 expression was evident upon immunohistochemical analysis of renal biopsies from KTRs. These results provide a snapshot of in-host BKV evolution and suggest that APOBEC3 may drive BKV mutagenesis in vivo. Published by Elsevier Inc.

Entities:  

Keywords:  APOBEC; APOBEC3; BKPyV; JCPyV; JCV; bladder; carcinoma; human polyomavirus; urothelial

Mesh:

Substances:

Year:  2018        PMID: 29746834      PMCID: PMC5953553          DOI: 10.1016/j.chom.2018.04.005

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  64 in total

1.  A detailed analysis of duplications appearing during early, high multiplicity infections with polyoma virus.

Authors:  H Kovar
Journal:  J Gen Virol       Date:  1991-08       Impact factor: 3.891

Review 2.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

3.  Human glial chimeric mice reveal astrocytic dependence of JC virus infection.

Authors:  Yoichi Kondo; Martha S Windrem; Lisa Zou; Devin Chandler-Militello; Steven J Schanz; Romane M Auvergne; Sarah J Betstadt; Amy R Harrington; Mahlon Johnson; Alexander Kazarov; Leonid Gorelik; Steven A Goldman
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

4.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.

Authors:  Eileen M Geoghegan; Diana V Pastrana; Rachel M Schowalter; Upasana Ray; Wei Gao; Mitchell Ho; Gary T Pauly; Dina M Sigano; Campbell Kaynor; Ellen Cahir-McFarland; Benoit Combaluzier; Jan Grimm; Christopher B Buck
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

5.  Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients: A cohort study of veterans.

Authors:  Ralph Rogers; Reginald Gohh; Amanda Noska
Journal:  Transpl Infect Dis       Date:  2017-09-16       Impact factor: 2.228

6.  Quantitation of human seroresponsiveness to Merkel cell polyomavirus.

Authors:  Diana V Pastrana; Yanis L Tolstov; Jürgen C Becker; Patrick S Moore; Yuan Chang; Christopher B Buck
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

Review 7.  BK Polyomavirus Infection and Renourinary Tumorigenesis.

Authors:  J C Papadimitriou; P Randhawa; C Hanssen Rinaldo; C B Drachenberg; B Alexiev; H H Hirsch
Journal:  Am J Transplant       Date:  2016-01-05       Impact factor: 8.086

8.  Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.

Authors:  Nicholas J Haradhvala; Paz Polak; Petar Stojanov; Kyle R Covington; Eve Shinbrot; Julian M Hess; Esther Rheinbay; Jaegil Kim; Yosef E Maruvka; Lior Z Braunstein; Atanas Kamburov; Philip C Hanawalt; David A Wheeler; Amnon Koren; Michael S Lawrence; Gad Getz
Journal:  Cell       Date:  2016-01-21       Impact factor: 41.582

9.  Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.

Authors:  Valdimara C Vieira; Brandon Leonard; Elizabeth A White; Gabriel J Starrett; Nuri A Temiz; Laurel D Lorenz; Denis Lee; Marcelo A Soares; Paul F Lambert; Peter M Howley; Reuben S Harris
Journal:  mBio       Date:  2014-12-23       Impact factor: 7.867

10.  SomaticSignatures: inferring mutational signatures from single-nucleotide variants.

Authors:  Julian S Gehring; Bernd Fischer; Michael Lawrence; Wolfgang Huber
Journal:  Bioinformatics       Date:  2015-07-10       Impact factor: 6.937

View more
  21 in total

1.  A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.

Authors:  Adam Z Cheng; Sofia N Moraes; Claire Attarian; Jaime Yockteng-Melgar; Matthew C Jarvis; Matteo Biolatti; Ganna Galitska; Valentina Dell'Oste; Lori Frappier; Craig J Bierle; Stephen A Rice; Reuben S Harris
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

Review 2.  BK polyomavirus diversity-Why viral variation matters.

Authors:  Jason T Blackard; Stella M Davies; Benjamin L Laskin
Journal:  Rev Med Virol       Date:  2020-03-03       Impact factor: 6.989

Review 3.  The case for BK polyomavirus as a cause of bladder cancer.

Authors:  Gabriel J Starrett; Christopher B Buck
Journal:  Curr Opin Virol       Date:  2019-07-20       Impact factor: 7.090

Review 4.  Intra-patient viral evolution in polyomavirus-related diseases.

Authors:  Dorian McIlroy; Franck Halary; Céline Bressollette-Bodin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  Optimized amplification of BK polyomavirus in urine.

Authors:  Elizabeth A Odegard; Heidi L Meeds; Steven B Kleiboeker; Assem Ziady; Anthony Sabulski; Sonata Jodele; Alix E Seif; Stella M Davies; Benjamin L Laskin; Jason T Blackard
Journal:  J Virol Methods       Date:  2021-10-07       Impact factor: 2.014

6.  Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.

Authors:  Sara Pautasso; Ganna Galitska; Valentina Dell'Oste; Matteo Biolatti; Rachele Cagliani; Diego Forni; Marco De Andrea; Marisa Gariglio; Manuela Sironi; Santo Landolfo
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

7.  Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.

Authors:  Noémie Lejeune; Florian Poulain; Kévin Willemart; Zoé Blockx; Sarah Mathieu; Nicolas A Gillet
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

8.  Mutational pressure by host APOBEC3s more strongly affects genes expressed early in the lytic phase of herpes simplex virus-1 (HSV-1) and human polyomavirus (HPyV) infection.

Authors:  Maxwell Shapiro; Laurie T Krug; Thomas MacCarthy
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

9.  Commentary on "Poor evidence for host-dependent regular RNA editing in the transcriptome of SARS-CoV-2".

Authors:  F Martignano; S Di Giorgio; G Mattiuz; S G Conticello
Journal:  J Appl Genet       Date:  2022-03-12       Impact factor: 2.653

10.  Persistent BK Polyomavirus Viruria is Associated with Accumulation of VP1 Mutations and Neutralization Escape.

Authors:  Dorian McIlroy; Mario Hönemann; Ngoc-Khanh Nguyen; Paul Barbier; Cécile Peltier; Audrey Rodallec; Franck Halary; Emilie Przyrowski; Uwe Liebert; Maryvonne Hourmant; Céline Bressollette-Bodin
Journal:  Viruses       Date:  2020-07-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.